Loading...
Azathioprine — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Azathioprine
2025-Q4
Comprehensive analysis of India’s azathioprine export trade — suppliers, buyers, prices, routes, and every shipment record.
86
Shipments
$2.66M
Trade Value
22
Suppliers
29
Buyers
26
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/azathioprine
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s azathioprine trade — 2025-Q4
KEY TAKEAWAY
Azathioprine 2025-Q4 exports total $2.7M across 26 countries, with RPG LIFE SCIENCES LTD commanding 52.6% market share.
TOTAL SHIPMENTS
86
2025-Q4
EXPORT VALUE
$2.7M
FOB USD
TOTAL QUANTITY
29.2M
units shipped
INDIAN SUPPLIERS
22
unique exporters
GLOBAL BUYERS
29
unique importers
DESTINATIONS
26
countries
MEDIAN UNIT PRICE
$1.17
per unit
TOP-5 SHARE
98.6%
of total USD
BRANDED SHARE
66.3%
57 shipments
DOSAGE FORMS
2
product types
6 KEY FINDINGS
1
RPG LIFE SCIENCES LTD is India's #1 Azathioprine exporter with $1.4M (52.6% market share).→ §5, Indian Supplier Rankings
2
Azathioprine reached 26 countries, with United States as the top destination ($1.0M).→ §4, Global Destination Map
3
Market concentration is high (HHI: 4094) — top 10 suppliers control 100.0% of exports.→ §5, Indian Supplier Rankings
4
96.6% of buyers (28 of 29) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (93.9%) across 2 dosage forms.→ §7, Price Benchmarks
6
26 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 RPG LIFE SCIENCES LTD leads in volume — how do 22 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian azathioprine exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Azathioprine report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial azathioprine trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian azathioprine suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Azathioprine India trade report
Product scope
Azathioprine
All variants merged — branded and generic formulations of azathioprine
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
86
Every commercial azathioprine trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a v-curve: Oct $776.4K, Nov $394.8K, Dec $1.5M. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$776.4K
Oct USD
11 shipments
2
$394.8K
Nov USD
-49.1% MoM
3
$1.5M
Dec USD
+278.0% MoM
4
V-curve
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 49.1% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $776K, making it the middle month by value.
Fig 3.2 Q4 cumulative USD reached $2.7M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $382K dip in Nov, $1.1M recovery in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Nov’s dip was fully recovered by Dec.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $776K | 11 shipments |
| Nov | $395K | 25 shipments |
| Dec | $1.5M | 50 shipments |
| Q4 Total | $2.7M | 86 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: United States held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: RPG LIFE SCIENCES LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import azathioprine from India, how much they buy, and who supplies each market
KEY TAKEAWAY
United States absorbs 38.9% of India’s 2025-Q4 azathioprine trade ($1.0M). Beyond the top 10 destinations, 26 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Americas has 7 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 26 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much azathioprine India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$94K
3.5% of trade
5 countries · 14 shipments
Europe
$616K
23.1% of trade
4 countries · 26 shipments
Americas
$1.8M
69.3% of trade
7 countries · 21 shipments
Africa
$7K
0.3% of trade
6 countries · 18 shipments
Oceania
$101K
3.8% of trade
4 countries · 7 shipments
Fig 4.1 United States is the #1 corridor ($1.0M) — 26 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian azathioprine it receives (light = low, dark = high). Orange arcs radiate from India to the top 26 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | United States | $1.0M | 12 | ZYDUS LIFESCIENCES LTD | $950K | AMNEAL PHARMACEUTICALS PVT LTD | $86K | — | — |
| 2 | Canada | $751K | 3 | RPG LIFE SCIENCES LTD | $751K | — | — | — | — |
| 3 | Germany | $276K | 20 | RPG LIFE SCIENCES LTD | $259K | GRANULES INDIA LTD | $18K | — | — |
| 4 | United Kingdom | $190K | 3 | RPG LIFE SCIENCES LTD | $190K | — | — | — | — |
| 5 | France | $140K | 2 | GRANULES INDIA LTD | $140K | — | — | — | — |
| 6 | Australia | $101K | 4 | RPG LIFE SCIENCES LTD | $101K | — | — | — | — |
| 7 | Thailand | $62K | 2 | RPG LIFE SCIENCES LTD | $62K | — | — | — | — |
| 8 | Colombia | $29K | 1 | RPG LIFE SCIENCES LTD | $29K | — | — | — | — |
| 9 | Iraq | $23K | 4 | CUBIT LIFESCIENCES LLP | $21K | VATS INDUSTRIES PVT LTD | $3K | — | — |
| 10 | Peru | $20K | 1 | GLOBELA PHARMA PVT LTD | $20K | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 3.5% of USD — but United States is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
38.9%
#1 country share
United States alone
89.8%
Top 5 share
5 of 26 countries
100.0%
Top 15 share
Long tail of 11 countries = 0.0%
HHI 2513
Destination HHI
Highly concentrated
26
Countries served
Global pharma reach from India
7
Americas countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
22 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
RPG LIFE SCIENCES LTD ($1.4M, 52.6% share) and ZYDUS LIFESCIENCES LTD ($949.6K) together control 88.3% of India’s 2025-Q4 azathioprine trade. The top 5 suppliers hold 98.6%. 22 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian azathioprine suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 RPG LIFE SCIENCES LTD leads by $453K over ZYDUS LIFESCIENCES LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: RMPL PHARMA LLP is #20 by value but #10 by volume.
Fig 5.2 RPG LIFE SCIENCES LTD also leads by shipment count (33) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: RMPL PHARMA LLP moves from #10 by volume to #20 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 22 azathioprine suppliers split into strategic segments
KEY TAKEAWAY
6 suppliers (25%) generate 99.3% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 RPG LIFE SCIENCES LTD and ZYDUS LIFESCIENCES LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 99.3% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | VATS INDUSTRIES PVT LTD | 2 | 2 | $3K |
| 2 | RPG LIFE SCIENCES LTD | 1 | 7 | $1.4M |
| 3 | ZYDUS LIFESCIENCES LTD | 1 | 1 | $950K |
| 4 | GRANULES INDIA LTD | 1 | 3 | $168K |
| 5 | AMNEAL PHARMACEUTICALS PVT LTD | 1 | 1 | $86K |
| 6 | CUBIT LIFESCIENCES LLP | 1 | 1 | $21K |
| 7 | GLOBELA PHARMA PVT LTD | 1 | 1 | $20K |
| 8 | WESTCOAST PHARMACEUTICAL WORKS LTD | 1 | 1 | $8K |
| 9 | BRUCK PHARMA PVT LTD | 1 | 2 | $6K |
| 10 | MDS ENTERPRISES | 1 | 2 | $547 |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the azathioprine manufacturing hubs
KEY TAKEAWAY
Ankleshwar and Ahmedabad together account for $2.4M of India’s 2025-Q4 azathioprine trade.
Fig 5.5 Ankleshwar (1 exporters, $1.4M) and Ahmedabad (3 exporters, $958K) are India’s azathioprine capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
98.6%
Top 5 share
5 of 22 suppliers
100.0%
Top 10 share
10 of 22 suppliers
99.3%
Top 25% share
6 suppliers = 99% USD
HHI 4094
Supplier HHI
Concentrated
22
Total suppliers
shipped Azathioprine in 2025-Q4
17+ cities
Indian hubs
Ankleshwar and Ahmedabad lead
§5.2 Coming next: 4 exporter deep-dive profiles
Each of the top 4 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | RPG LIFE SCIENCES LTD | $1.4M |
| #2 | GRANULES INDIA LTD | $168K |
| #3 | VATS INDUSTRIES PVT LTD | $3K |
| #4 | MDS ENTERPRISES | $547 |
#1
EXPORTER PROFILE #1 OF 4
RPG LIFE SCIENCES LTD
Ankleshwar · India’s #1 azathioprine supplier by USD · 2025-Q4
2025-Q4 USD
$1.4M
52.6% market share
SHIPMENTS
33
avg $42K/ship
COUNTRIES
7
destination markets
BUYERS
10
10 single-sourced
BRANDED
67%
of shipments
DOSAGE FORMS
1
product types
TOP 7 DESTINATIONS
Canada is the #1 market at $751K (54% of trade), followed by Germany at $259K. 7 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Canada | $751K | 3 | 53.5% |
| 2 | Germany | $259K | 18 | 18.4% |
| 3 | United Kingdom | $190K | 3 | 13.5% |
| 4 | Australia | $101K | 4 | 7.2% |
| 5 | Thailand | $62K | 2 | 4.4% |
| 6 | Colombia | $29K | 1 | 2.1% |
| 7 | Trinidad and Tobago | $12K | 2 | 0.9% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $1.2M.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 10/10 LOCKED IN
10 of 10 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| APOTEX INC | Canada | $751K | ⚠ Locked |
| AQVIDA GMBH | Germany | $258K | ⚠ Locked |
| TILLOMED LABORATORIES … | United Kingdom | $102K | ⚠ Locked |
| ELARA PHARMASERVICES LTD | United Kingdom | $88K | ⚠ Locked |
| ARROW PHARMACEUTICALS … | Australia | $68K | ⚠ Locked |
| PINYOPHARMACY LTD | Thailand | $62K | ⚠ Locked |
| GENERIC PARTNERS PTY LTD | Australia | $33K | ⚠ Locked |
| NEXT PHARMA SOURCING SAS | Colombia | $29K | ⚠ Locked |
| MEDI SUPPLIES LTD | Trinidad and Tobago | $12K | ⚠ Locked |
| MERCKLE GMBH | Germany | $574 | ⚠ Locked |
#1
EXPORTER PROFILE #1 OF 4 — TRADE FLOW MAP
RPG LIFE SCIENCES LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P1.3 Canada absorbs $751K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 2 importers per destination.
#3
EXPORTER PROFILE #2 OF 4
GRANULES INDIA LTD
Visakhapatnam · India’s #3 azathioprine supplier by USD · 2025-Q4
2025-Q4 USD
$168K
6.3% market share
SHIPMENTS
5
avg $34K/ship
COUNTRIES
3
destination markets
BUYERS
4
4 single-sourced
BRANDED
80%
of shipments
DOSAGE FORMS
1
product types
TOP 3 DESTINATIONS
France is the #1 market at $140K (84% of trade), followed by Germany at $18K. 3 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | France | $140K | 2 | 83.7% |
| 2 | Germany | $18K | 2 | 10.6% |
| 3 | Netherlands | $10K | 1 | 5.7% |
MONTHLY TREND
Oct peaked at $168K. Nov was the weakest at $0.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 4/4 LOCKED IN
4 of 4 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| CSP VIATRIS SA | France | $128K | ⚠ Locked |
| VIATRIS HEALTHCARE GMBH | Germany | $18K | ⚠ Locked |
| CSP P/O VIATRIS SA | France | $12K | ⚠ Locked |
| MYLAN IRELAND LTD | Netherlands | $10K | ⚠ Locked |
#3
EXPORTER PROFILE #2 OF 4 — TRADE FLOW MAP
GRANULES INDIA LTD — Supplier → Country → Importer
3 destination countries, top 5 importers per country
Fig 5.P2.3 France absorbs $140K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 2 importers per destination.
#9
EXPORTER PROFILE #3 OF 4
VATS INDUSTRIES PVT LTD
New Delhi · India’s #9 azathioprine supplier by USD · 2025-Q4
2025-Q4 USD
$3K
0.1% market share
SHIPMENTS
5
avg $540/ship
COUNTRIES
2
destination markets
BUYERS
3
2 single-sourced
BRANDED
100%
of shipments
DOSAGE FORMS
2
product types
TOP 2 DESTINATIONS
Iraq is the #1 market at $3K (100% of trade), followed by Afghanistan at $0. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Iraq | $3K | 3 | 100.0% |
| 2 | Afghanistan | $0 | 2 | 0.0% |
MONTHLY TREND
Nov peaked at $3K. Oct was the weakest at $0.
PRODUCT MIX
Unknown dominates at 67% of trade. Tablet (33.3%) and Injection are secondary formulations.
TOP BUYERS · 2/2 LOCKED IN
2 of 2 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Iraq | $2K | N/A |
| ATLAS TRADING COMPANY | Iraq | $900 | ⚠ Locked |
| TRUST ANESTHETIC LTD | Afghanistan | $0 | ⚠ Locked |
#9
EXPORTER PROFILE #3 OF 4 — TRADE FLOW MAP
VATS INDUSTRIES PVT LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P3.3 Iraq absorbs $3K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
#10
EXPORTER PROFILE #4 OF 4
MDS ENTERPRISES
Mumbai · India’s #10 azathioprine supplier by USD · 2025-Q4
2025-Q4 USD
$547
0.0% market share
SHIPMENTS
6
avg $91/ship
COUNTRIES
2
destination markets
BUYERS
1
unique importers
BRANDED
100%
of shipments
DOSAGE FORMS
1
product types
TOP 2 DESTINATIONS
Ghana is the #1 market at $541 (99% of trade), followed by United Arab Emirates at $6. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Ghana | $541 | 3 | 99.0% |
| 2 | United Arab Emirates | $6 | 3 | 1.0% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $312.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 0 BUYERS
Buyers are well-diversified across multiple Indian suppliers.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Ghana | $547 | N/A |
#10
EXPORTER PROFILE #4 OF 4 — TRADE FLOW MAP
MDS ENTERPRISES — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P4.3 Ghana absorbs $541 — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
29 importers across 26 countries — who is buying Indian azathioprine and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 98.6% of total USD. 97% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian azathioprine. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 EVERSANA LIFE SCIENCE SERVICES LLC is the #1 importer at $950K (35.6%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
97%
Single-source
28 buyers rely on exactly 1 Indian supplier
0%
Dual-source
0 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
3%
Broad-source (5+)
1 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source azathioprine from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Germany 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| AQVIDA GMBH | RPG LIFE SCIENCES LTD | $258K | $0.621 | Tablet |
| VIATRIS HEALTHCARE GMBH | GRANULES INDIA LTD | $18K | $0.048 | Tablet |
| MERCKLE GMBH | RPG LIFE SCIENCES LTD | $573.540 | $0.059 | Tablet |
United States 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| EVERSANA LIFE SCIENCE … | ZYDUS LIFESCIENCES LTD | $950K | $0.086 | Tablet |
| AMNEAL PHARMACEUTICALS… | AMNEAL PHARMACEUTICA… | $86K | $9.409 | Tablet |
France 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| CSP VIATRIS SA | GRANULES INDIA LTD | $128K | $0.047 | Tablet |
| CSP P/O VIATRIS SA | GRANULES INDIA LTD | $12K | $0.046 | Tablet |
United Kingdom 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| TILLOMED LABORATORIES … | RPG LIFE SCIENCES LTD | $102K | $0.988 | Tablet |
| ELARA PHARMASERVICES LTD | RPG LIFE SCIENCES LTD | $88K | $0.045 | Tablet |
Australia 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ARROW PHARMACEUTICALS … | RPG LIFE SCIENCES LTD | $68K | $5.964 | Tablet |
| GENERIC PARTNERS PTY LTD | RPG LIFE SCIENCES LTD | $33K | $0.068 | Tablet |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENC… | United States | $950K | $119K | Premium |
| 2 | APOTEX INC | Canada | $751K | $250K | Premium |
| 3 | AQVIDA GMBH | Germany | $258K | $15K | Mid |
| 4 | CSP VIATRIS SA | France | $128K | $128K | Premium |
| 5 | TILLOMED LABORATORIE… | United Kingdom | $102K | $102K | Premium |
| 6 | ELARA PHARMASERVICES… | United Kingdom | $88K | $44K | Premium |
| 7 | AMNEAL PHARMACEUTICA… | United States | $86K | $21K | Mid |
| 8 | ARROW PHARMACEUTICAL… | Australia | $68K | $23K | Mid |
| 9 | PINYOPHARMACY LTD | Thailand | $62K | $31K | Mid |
| 10 | GENERIC PARTNERS PTY… | Australia | $33K | $33K | Mid |
| 11 | NEXT PHARMA SOURCING… | Colombia | $29K | $29K | Mid |
| 12 | MINISTRY OF HEALTH T… | Iraq | $21K | $21K | Mid |
| 13 | VIATRIS HEALTHCARE G… | Germany | $18K | $9K | Budget |
| 14 | CSP P/O VIATRIS SA | France | $12K | $12K | Budget |
| 15 | MEDI SUPPLIES LTD | Trinidad and Tobago | $12K | $6K | Budget |
| 16 | MYLAN IRELAND LTD | Netherlands | $10K | $10K | Budget |
| 17 | ATLAS TRADING COMPANY | Iraq | $899.884 | $900.000 | Budget |
| 18 | MERCKLE GMBH | Germany | $573.540 | $574.000 | Budget |
| 19 | ETEMAD MOSLEH LTD | Afghanistan | $199.773 | $200.000 | Budget |
| 20 | MED-CHIP PHARMACY | Zimbabwe | $164.663 | $55.000 | Budget |
| 21 | SALAMA PHARMACUTICAL… | Kenya | $60.180 | $60.000 | Budget |
| 22 | REPUBLIC OF NAURU - … | Nauru | $15.319 | $15.000 | Budget |
| 23 | MIOT INVESTMENTS (FI… | Fiji | $8.985 | $9.000 | Budget |
| 24 | T. CHOITHRAM & SONS | Sierra Leone | $8.137 | $8.000 | Budget |
| 25 | EMCURE PHARMA CHILE … | Chile | $0.0062 | $0.0000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 RPG LIFE SCIENCES LTD → EVERSANA LIFE SCIENCE SERVICES LLC is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian azathioprine prices vary by supplier, country and dosage form
KEY TAKEAWAY
Azathioprine prices span 9751× ($0.0014 → $14.05). The coefficient of variation is 1.30. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0014 | Lowest observed unit price |
| P5 | $0.0056 | 5th percentile |
| P25 | $0.048 | 25th percentile (Q1) |
| Median | $1.17 | 50th percentile (Q2) |
| P75 | $4.33 | 75th percentile (Q3) |
| P95 | $11.23 | 95th percentile |
| Max | $14.05 | Highest observed unit price |
| Mean | $2.83 | Arithmetic average |
| CV | 130% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 VATS INDUSTRIES PVT LTD prices at $12.86/unit vs market median $1.17.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. ZYDUS LIFESCIENCES LTD Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. RPG LIFE SCIENCES Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | RPG LIFE SCIENCE… | Trinidad and Tobago | Tablet | 100 | $1K | $14.05 | Specialty / small-batch |
| Nov 2025 | VATS INDUSTRIES … | Iraq | — | 70 | $899.89 | $12.86 | Specialty / small-batch |
| Nov 2025 | VATS INDUSTRIES … | Iraq | Tablet | 70 | $899.88 | $12.86 | Specialty / small-batch |
| Nov 2025 | VATS INDUSTRIES … | Iraq | — | 70 | $899.88 | $12.86 | Specialty / small-batch |
| Nov 2025 | BRUCK PHARMA PVT… | Lesotho | Tablet | 296 | $3K | $10.94 | Specialty / small-batch |
| Dec 2025 | AMNEAL PHARMACEU… | United States | Tablet | 2K | $20K | $10.13 | Specialty / small-batch |
| Dec 2025 | AMNEAL PHARMACEU… | United States | Tablet | 4K | $45K | $10.13 | Specialty / small-batch |
| Dec 2025 | AMNEAL PHARMACEU… | United States | Tablet | 682 | $6K | $8.13 | Specialty / small-batch |
| Nov 2025 | BRUCK PHARMA PVT… | Lesotho | Tablet | 296 | $2K | $7.75 | Specialty / small-batch |
| Oct 2025 | AMNEAL PHARMACEU… | United States | Tablet | 2K | $15K | $7.51 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | RMPL PHARMA LLP | Tanzania | Tablet | 20 | $0.029 | $0.0014 | Bulk generic tablet |
| Dec 2025 | RMPL PHARMA LLP | Tanzania | Tablet | 180 | $0.260 | $0.0014 | Bulk generic tablet |
| Dec 2025 | BARAKAH BIOHEALT… | Tanzania | Tablet | 520 | $1.32 | $0.0025 | Bulk generic tablet |
| Dec 2025 | BARAKAH BIOHEALT… | Tanzania | Tablet | 480 | $1.22 | $0.0025 | Bulk generic tablet |
| Dec 2025 | EMCURE PHARMACEU… | Chile | Tablet | 1 | $0.0062 | $0.0062 | Bulk generic tablet |
| Dec 2025 | MDS ENTERPRISES | United Arab Emirates | Tablet | 100 | $1.71 | $0.017 | Small sample / trial shipment |
| Dec 2025 | MDS ENTERPRISES | United Arab Emirates | Tablet | 200 | $3.99 | $0.020 | Small sample / trial shipment |
| Dec 2025 | HLL LIFECARE LTD | Nauru | Tablet | 751 | $15.32 | $0.020 | Small sample / trial shipment |
| Dec 2025 | RPG LIFE SCIENCE… | United Kingdom | Tablet | 1.9M | $44K | $0.023 | Bulk volume discount |
| Oct 2025 | ZYDUS LIFESCIENC… | United States | Tablet | 1.6M | $48K | $0.029 | Bulk volume discount |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship azathioprine, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Azathioprine leaves India through 8+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), MUNDRA SEA, HYDERABAD AIR) handle 99.6% of total USD. SEA moves 37% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $1.2M — top 8 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 Toronto is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
SEA dominates at 37% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$2.2M
83.0% of USD · 37.2% of ships
AIR
$444K
16.7% of USD · 61.6% of ships
ICD
$8K
0.3% of USD · 1.2% of ships
Fig 8.3 The dominant corridor is MUNDRA SEA → Sea → N. America ($1.0M).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Australia is the most concentrated destination (HHI 10000, 1 suppliers). Zimbabwe is the most competitive (HHI 6700).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Australia (HHI 10,000) is the most concentrated — Zimbabwe (HHI 6,700) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| EVERSANA LIFE SCIENC… | United States | ZYDUS LIFESCIENC… | $950K | 8 | CRITICAL |
| APOTEX INC | Canada | RPG LIFE SCIENCE… | $751K | 3 | CRITICAL |
| AQVIDA GMBH | Germany | RPG LIFE SCIENCE… | $258K | 17 | HIGH |
| CSP VIATRIS SA | France | GRANULES INDIA LTD | $128K | 1 | HIGH |
| TILLOMED LABORATORIE… | United Kingdom | RPG LIFE SCIENCE… | $102K | 1 | HIGH |
| ELARA PHARMASERVICES… | United Kingdom | RPG LIFE SCIENCE… | $88K | 2 | MEDIUM |
| AMNEAL PHARMACEUTICA… | United States | AMNEAL PHARMACEU… | $86K | 4 | MEDIUM |
| ARROW PHARMACEUTICAL… | Australia | RPG LIFE SCIENCE… | $68K | 3 | MEDIUM |
Conclusion: 27 buyers depend on exactly one Indian supplier, representing $2.6M in trade. 2 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| United States | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Canada | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Germany | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| United Kingdom | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| France | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Australia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Thailand | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Colombia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Iraq | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Peru | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Trinidad and Tobago | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Netherlands | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Myanmar | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Lesotho | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Ghana | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 14 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in United States | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Australia lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Germany (2 suppliers) | This Q | HIGH |
| A6 | Enter United States (2 suppliers) | This Q | MED |
| A8 | Build Canada distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for United States tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Germany | Other | 2 | $276K | +642.2% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | United States | Other | 2 | $1.0M | -56.5% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Canada | Other | 1 | $751K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | United Kingdom | Other | 1 | $190K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | France | Other | 1 | $140K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Australia | Other | 1 | $101K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Thailand | Asia | 1 | $62K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Colombia | Other | 1 | $29K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Iraq | Other | 2 | $23K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Peru | Other | 1 | $20K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Trinidad and Tobago | Other | 1 | $12K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Netherlands | Other | 1 | $10K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Myanmar | Asia | 2 | $8K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Lesotho | Africa | 1 | $6K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Ghana | Africa | 1 | $541 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 86 2025-Q4 Azathioprine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/azathioprine
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 86 2025-Q4 azathioprine shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian azathioprine shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
86
across all regions
TOTAL USD
$2.66M
2025-Q4 FOB value
UNITS
29.2M
tablets, capsules, etc.
SUPPLIERS
22
Indian exporters
BUYERS
29
global importers
COUNTRIES
26
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $7K (0.3%), spanning 6 countries.
22 Indian suppliers shipped to 29 buyers across 26 countries — average shipment value $31K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
6 countries · 18 shipments · $7K · 8 Indian suppliers · 4 buyers
SHIPMENTS
18
USD
$7K
COUNTRIES
6
SUPPLIERS
8
BUYERS
4
HHI
6,947
concentrated
Top 6 destination countries in Africa
1
Lesotho (82.8%)
$6K
2
Ghana (8.1%)
$541.33
3
Tanzania (5.0%)
$334.68
4
Zimbabwe (3.1%)
$208.04
5
Kenya (0.9%)
$60.18
6
Sierra Leone (0.1%)
$8.14
Top 8 Indian suppliers into Africa
1
BRUCK PHARMA PVT LTD
$6K
2
MDS ENTERPRISES
$541.33
3
BARAKAH BIOHEALTH LLP
$334.39
4
S P PHARMA ENTERPRISES
$164.66
5
M T MADON EXPORTS
$60.18
6
RUTVA MEDICARE
$43.37
7
GIANT INTERNATIONAL PVT LTD
$8.14
8
RMPL PHARMA LLP
$0.288
Top 3 Africa importers
1
MED-CHIP PHARMACY · Zimbabwe
$164.66
2
SALAMA PHARMACUTICALS LTD · Kenya
$60.18
3
T. CHOITHRAM & SONS · Sierra Leone
$8.14
Top 2 dosage forms
1
Tablet
$7K
2
Injection
$8.14
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 5 | $6K | $1K |
| Dec | 13 | $694.84 | $53.45 |
Shipment register · 18 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — BRUCK PHARMA PVT LTD · 2 shipments · $6K | |||||||||||
| 1 | Nov 2025 | UNLISTED BUYER | Lesotho | Tablet | 296 | NOS | $10.94 | $3K | MUMBAI AIR (SAHAR) | MASERU | AIR |
| 2 | Nov 2025 | UNLISTED BUYER | Lesotho | Tablet | 296 | NOS | $7.75 | $2K | MUMBAI AIR (SAHAR) | MASERU | AIR |
| SUPPLIER #2 — MDS ENTERPRISES · 3 shipments · $541.33 | |||||||||||
| 3 | Nov 2025 | UNLISTED BUYER | Ghana | Tablet | 100 | NOS | $1.17 | $117.45 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 4 | Nov 2025 | UNLISTED BUYER | Ghana | Tablet | 100 | NOS | $1.17 | $117.45 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 5 | Dec 2025 | UNLISTED BUYER | Ghana | Tablet | 200 | NOS | $1.53 | $306.43 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #3 — BARAKAH BIOHEALTH LLP · 5 shipments · $334.39 | |||||||||||
| 6 | Nov 2025 | UNLISTED BUYER | Tanzania | Tablet | 1.0K | NOS | $0.223 | $222.62 | CHENNAI AIR | DAR ES SALAM (DARESS | AIR |
| 7 | Dec 2025 | UNLISTED BUYER | Tanzania | Tablet | 480 | NOS | $0.228 | $109.23 | CHENNAI AIR | DAR ES SALAM (DARESS | AIR |
| 8 | Dec 2025 | UNLISTED BUYER | Tanzania | Tablet | 480 | NOS | $0.0025 | $1.22 | CHENNAI AIR | DAR ES SALAM (DARESS | AIR |
| 9 | Dec 2025 | UNLISTED BUYER | Tanzania | Tablet | 480 | NOS | $0.0000 | $0.0000 | CHENNAI AIR | DAR ES SALAM (DARESS | AIR |
| 10 | Dec 2025 | UNLISTED BUYER | Tanzania | Tablet | 520 | NOS | $0.0025 | $1.32 | CHENNAI AIR | DAR ES SALAM (DARESS | AIR |
| SUPPLIER #4 — S P PHARMA ENTERPRISES · 3 shipments · $164.66 | |||||||||||
| 11 | Dec 2025 | MED-CHIP PHARMACY | Zimbabwe | Tablet | 30 | NOS | $2.73 | $81.86 | MUMBAI AIR (SAHAR) | HARARE | AIR |
| 12 | Dec 2025 | MED-CHIP PHARMACY | Zimbabwe | Tablet | 30 | NOS | $2.73 | $81.76 | MUMBAI AIR (SAHAR) | HARARE | AIR |
| 13 | Dec 2025 | MED-CHIP PHARMACY | Zimbabwe | Tablet | 30 | NOS | $0.035 | $1.05 | MUMBAI AIR (SAHAR) | HARARE | AIR |
| SUPPLIER #5 — M T MADON EXPORTS · 1 shipments · $60.18 | |||||||||||
| 14 | Dec 2025 | SALAMA PHARMACUTICALS LTD | Kenya | Tablet | 400 | NOS | $0.150 | $60.18 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #6 — RUTVA MEDICARE · 1 shipments · $43.37 | |||||||||||
| 15 | Dec 2025 | UNLISTED BUYER | Zimbabwe | Tablet | 50 | PCS | $0.867 | $43.37 | AHMEDABAD AIR | HARARE | AIR |
| SUPPLIER #7 — GIANT INTERNATIONAL PVT LTD · 1 shipments · $8.14 | |||||||||||
| 16 | Dec 2025 | T. CHOITHRAM & SONS | Sierra Leone | Injection | 10 | PCS | $0.814 | $8.14 | NHAVA SHEVA SEA (JNPT) | Freetown | SEA |
| SUPPLIER #8 — RMPL PHARMA LLP · 2 shipments · $0.288 | |||||||||||
| 17 | Dec 2025 | UNLISTED BUYER | Tanzania | Tablet | 20 | NOS | $0.0014 | $0.029 | MUMBAI AIR (SAHAR) | DAR ES SALAM (DARESS | AIR |
| 18 | Dec 2025 | UNLISTED BUYER | Tanzania | Tablet | 180 | NOS | $0.0014 | $0.260 | MUMBAI AIR (SAHAR) | DAR ES SALAM (DARESS | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
5 countries · 14 shipments · $94K · 7 Indian suppliers · 7 buyers
SHIPMENTS
14
USD
$94K
COUNTRIES
5
SUPPLIERS
7
BUYERS
7
HHI
4,901
concentrated
Top 5 destination countries in Asia
1
Thailand (65.8%)
$62K
2
Iraq (25.1%)
$23K
3
Myanmar (8.9%)
$8K
4
Afghanistan (0.2%)
$199.77
5
United Arab Emirates (0.0%)
$5.69
Top 7 Indian suppliers into Asia
1
RPG LIFE SCIENCES LTD
$62K
2
CUBIT LIFESCIENCES LLP
$21K
3
WESTCOAST PHARMACEUTICAL WORKS LTD
$8K
4
VATS INDUSTRIES PVT LTD
$3K
5
BRUCK PHARMA PVT LTD
$352.28
6
BAKER & DAVIS PVT LTD
$199.77
7
MDS ENTERPRISES
$5.69
Top 5 Asia importers
1
PINYOPHARMACY LTD · Thailand
$62K
2
MINISTRY OF HEALTH THE STATE COMPAN · Iraq
$21K
3
ATLAS TRADING COMPANY · Iraq
$899.88
4
ETEMAD MOSLEH LTD · Afghanistan
$199.77
5
TRUST ANESTHETIC LTD · Afghanistan
$0.0000
Top 3 dosage forms
1
Tablet
$92K
2
Unknown
$2K
3
Injection
$0.0000
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 7 | $32K | $5K |
| Dec | 7 | $62K | $9K |
Shipment register · 14 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — RPG LIFE SCIENCES LTD · 2 shipments · $62K | |||||||||||
| 1 | Dec 2025 | PINYOPHARMACY LTD | Thailand | Tablet | 1.3K | NOS | $6.42 | $8K | MUMBAI AIR (SAHAR) | BANGKOK | AIR |
| 2 | Dec 2025 | PINYOPHARMACY LTD | Thailand | Tablet | 8.3K | NOS | $6.43 | $53K | MUMBAI AIR (SAHAR) | BANGKOK | AIR |
| SUPPLIER #2 — CUBIT LIFESCIENCES LLP · 1 shipments · $21K | |||||||||||
| 3 | Nov 2025 | MINISTRY OF HEALTH THE STATE COMPAN | Iraq | Tablet | 12.2K | PCS | $1.70 | $21K | AHMEDABAD AIR | BAGDAD, METROPOLITAN | AIR |
| SUPPLIER #3 — WESTCOAST PHARMACEUTICAL WORKS LTD · 1 shipments · $8K | |||||||||||
| 4 | Nov 2025 | UNLISTED BUYER | Myanmar | Tablet | 3.9K | NOS | $2.05 | $8K | AHMEDABAD ICD | YANGON | ICD |
| SUPPLIER #4 — VATS INDUSTRIES PVT LTD · 5 shipments · $3K | |||||||||||
| 5 | Nov 2025 | ATLAS TRADING COMPANY | Iraq | Tablet | 70 | NOS | $12.86 | $899.88 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| 6 | Nov 2025 | UNKNOWN BUYER | Iraq | 70 | NOS | $12.86 | $899.88 | DELHI AIR | BAGDAD, METROPOLITAN | AIR | |
| 7 | Nov 2025 | UNKNOWN BUYER | Iraq | 70 | NOS | $12.86 | $899.89 | DELHI AIR | BAGDAD, METROPOLITAN | AIR | |
| 8 | Dec 2025 | TRUST ANESTHETIC LTD | Afghanistan | Injection | 74 | NOS | $0.0000 | $0.0000 | DELHI AIR | KABUL | AIR |
| 9 | Dec 2025 | TRUST ANESTHETIC LTD | Afghanistan | Injection | 176 | NOS | $0.0000 | $0.0000 | DELHI AIR | KABUL | AIR |
| SUPPLIER #5 — BRUCK PHARMA PVT LTD · 1 shipments · $352.28 | |||||||||||
| 10 | Nov 2025 | UNLISTED BUYER | Myanmar | Tablet | 50 | NOS | $7.05 | $352.28 | MUMBAI AIR (SAHAR) | YANGON | AIR |
| SUPPLIER #6 — BAKER & DAVIS PVT LTD · 1 shipments · $199.77 | |||||||||||
| 11 | Nov 2025 | ETEMAD MOSLEH LTD | Afghanistan | Tablet | 2.0K | NOS | $0.100 | $199.77 | DELHI AIR | KABUL | AIR |
| SUPPLIER #7 — MDS ENTERPRISES · 3 shipments · $5.69 | |||||||||||
| 12 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Tablet | 100 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 13 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Tablet | 100 | NOS | $0.017 | $1.71 | MUMBAI AIR (SAHAR) | SHARJAH | AIR |
| 14 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Tablet | 200 | NOS | $0.020 | $3.99 | MUMBAI AIR (SAHAR) | SHARJAH | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
4 countries · 26 shipments · $616K · 2 Indian suppliers · 8 buyers
SHIPMENTS
26
USD
$616K
COUNTRIES
4
SUPPLIERS
2
BUYERS
8
HHI
6,039
concentrated
Top 4 destination countries in Europe
1
Germany (44.9%)
$276K
2
United Kingdom (30.8%)
$190K
3
France (22.8%)
$140K
4
Netherlands (1.6%)
$10K
Top 2 Indian suppliers into Europe
1
RPG LIFE SCIENCES LTD
$448K
2
GRANULES INDIA LTD
$168K
Top 8 Europe importers
1
AQVIDA GMBH · Germany
$258K
2
CSP VIATRIS SA · France
$128K
3
TILLOMED LABORATORIES LTD · United Kingdom
$102K
4
ELARA PHARMASERVICES LTD · United Kingdom
$88K
5
VIATRIS HEALTHCARE GMBH · Germany
$18K
6
CSP P/O VIATRIS SA · France
$12K
7
MYLAN IRELAND LTD · Netherlands
$10K
8
MERCKLE GMBH · Germany
$573.54
Top 1 dosage forms
1
Tablet
$616K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 5 | $168K | $34K |
| Nov | 7 | $127K | $18K |
| Dec | 14 | $321K | $23K |
Shipment register · 26 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — RPG LIFE SCIENCES LTD · 21 shipments · $448K | |||||||||||
| 1 | Nov 2025 | AQVIDA GMBH | Germany | Tablet | 9.1K | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Hamburg | SEA |
| 2 | Nov 2025 | AQVIDA GMBH | Germany | Tablet | 4.9K | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Hamburg | SEA |
| 3 | Nov 2025 | AQVIDA GMBH | Germany | Tablet | 1.2K | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Hamburg | SEA |
| 4 | Nov 2025 | AQVIDA GMBH | Germany | Tablet | 18.4K | NOS | $3.16 | $58K | NHAVA SHEVA SEA (JNPT) | Hamburg | SEA |
| 5 | Nov 2025 | AQVIDA GMBH | Germany | Tablet | 9.1K | NOS | $4.93 | $45K | NHAVA SHEVA SEA (JNPT) | Hamburg | SEA |
| 6 | Nov 2025 | AQVIDA GMBH | Germany | Tablet | 4.9K | NOS | $4.03 | $20K | NHAVA SHEVA SEA (JNPT) | Hamburg | SEA |
| 7 | Nov 2025 | AQVIDA GMBH | Germany | Tablet | 1.2K | NOS | $4.03 | $5K | NHAVA SHEVA SEA (JNPT) | Hamburg | SEA |
| 8 | Dec 2025 | AQVIDA GMBH | Germany | Tablet | 334.8K | TBS | $0.030 | $10K | MUMBAI AIR (SAHAR) | HAMBURG - FUHLSBUETT | AIR |
| 9 | Dec 2025 | MERCKLE GMBH | Germany | Tablet | 9.7K | NOS | $0.059 | $573.54 | NHAVA SHEVA SEA (JNPT) | Hamburg | AIR |
| 10 | Dec 2025 | ELARA PHARMASERVICES LTD | United Kingdom | Tablet | 1.9M | NOS | $0.023 | $44K | NHAVA SHEVA SEA (JNPT) | LONDON GATWAY PORT | SEA |
| 11 | Dec 2025 | ELARA PHARMASERVICES LTD | United Kingdom | Tablet | 67.6K | NOS | $0.650 | $44K | NHAVA SHEVA SEA (JNPT) | LONDON GATWAY PORT | SEA |
| 12 | Dec 2025 | AQVIDA GMBH | Germany | Tablet | 14.5K | NOS | $4.58 | $66K | NHAVA SHEVA SEA (JNPT) | Hamburg | SEA |
| 13 | Dec 2025 | AQVIDA GMBH | Germany | Tablet | 1.0K | NOS | $3.13 | $3K | NHAVA SHEVA SEA (JNPT) | Hamburg | SEA |
| 14 | Dec 2025 | AQVIDA GMBH | Germany | Tablet | 1.9K | NOS | $1.66 | $3K | NHAVA SHEVA SEA (JNPT) | Hamburg | SEA |
| 15 | Dec 2025 | AQVIDA GMBH | Germany | Tablet | 672 | NOS | $2.69 | $2K | NHAVA SHEVA SEA (JNPT) | Hamburg | SEA |
| 16 | Dec 2025 | AQVIDA GMBH | Germany | Tablet | 4.9K | NOS | $4.43 | $22K | NHAVA SHEVA SEA (JNPT) | Hamburg | SEA |
| 17 | Dec 2025 | TILLOMED LABORATORIES LTD | United Kingdom | Tablet | 103.1K | NOS | $0.988 | $102K | NHAVA SHEVA SEA (JNPT) | Felixstowe | SEA |
| 18 | Dec 2025 | AQVIDA GMBH | Germany | Tablet | 2.4K | NOS | $4.80 | $11K | MUMBAI AIR (SAHAR) | HAMBURG - FUHLSBUETT | AIR |
| 19 | Dec 2025 | AQVIDA GMBH | Germany | Tablet | 2.0K | NOS | $3.07 | $6K | MUMBAI AIR (SAHAR) | HAMBURG - FUHLSBUETT | AIR |
| 20 | Dec 2025 | AQVIDA GMBH | Germany | Tablet | 2.0K | NOS | $1.62 | $3K | MUMBAI AIR (SAHAR) | HAMBURG - FUHLSBUETT | AIR |
| 21 | Dec 2025 | AQVIDA GMBH | Germany | Tablet | 2.9K | NOS | $1.37 | $4K | MUMBAI AIR (SAHAR) | HAMBURG - FUHLSBUETT | AIR |
| SUPPLIER #2 — GRANULES INDIA LTD · 5 shipments · $168K | |||||||||||
| 22 | Oct 2025 | VIATRIS HEALTHCARE GMBH | Germany | Tablet | 261.6K | NOS | $0.047 | $12K | HYDERABAD AIR | FRANKFURT/MAIN INT'L | AIR |
| 23 | Oct 2025 | CSP VIATRIS SA | France | Tablet | 2.7M | NOS | $0.047 | $128K | HYDERABAD AIR | LYON | AIR |
| 24 | Oct 2025 | VIATRIS HEALTHCARE GMBH | Germany | Tablet | 107.8K | NOS | $0.050 | $5K | HYDERABAD AIR | FRANKFURT/MAIN INT'L | AIR |
| 25 | Oct 2025 | CSP P/O VIATRIS SA | France | Tablet | 261.0K | NOS | $0.046 | $12K | HYDERABAD AIR | LYON | AIR |
| 26 | Oct 2025 | MYLAN IRELAND LTD | Netherlands | Tablet | 207.0K | NOS | $0.046 | $10K | HYDERABAD AIR | AMSTERDAM, SCHIPHOL | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
7 countries · 21 shipments · $1.85M · 6 Indian suppliers · 8 buyers
SHIPMENTS
21
USD
$1.85M
COUNTRIES
7
SUPPLIERS
6
BUYERS
8
HHI
4,506
concentrated
Top 7 destination countries in Americas
1
United States (56.1%)
$1.04M
2
Canada (40.7%)
$751K
3
Colombia (1.6%)
$29K
4
Peru (1.1%)
$20K
5
Trinidad and Tobago (0.7%)
$12K
6
Chile (0.0%)
$0.0062
7
Jamaica · Jamaica
$0.0000
Top 6 Indian suppliers into Americas
1
ZYDUS LIFESCIENCES LTD
$950K
2
RPG LIFE SCIENCES LTD
$792K
3
AMNEAL PHARMACEUTICALS PVT LTD
$86K
4
GLOBELA PHARMA PVT LTD
$20K
5
EMCURE PHARMACEUTICALS LTD
$0.0062
6
CIPLA LTD
$0.0000
Top 7 Americas importers
1
EVERSANA LIFE SCIENCE SERVICES LLC · United States
$950K
2
APOTEX INC · Canada
$751K
3
AMNEAL PHARMACEUTICALS LLC · United States
$86K
4
NEXT PHARMA SOURCING SAS · Colombia
$29K
5
MEDI SUPPLIES LTD · Trinidad and Tobago
$12K
6
EMCURE PHARMA CHILE S.P.A · Chile
$0.0062
7
LASCO DISTRIBUTORS LTD · Jamaica
$0.0000
Top 2 dosage forms
1
Tablet
$1.69M
2
Unknown
$161K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 6 | $609K | $101K |
| Nov | 1 | $161K | $161K |
| Dec | 14 | $1.08M | $77K |
Shipment register · 21 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ZYDUS LIFESCIENCES LTD · 8 shipments · $950K | |||||||||||
| 1 | Oct 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Tablet | 1.6M | NOS | $0.029 | $48K | MUNDRA SEA | SAVANNAH | SEA |
| 2 | Oct 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Tablet | 1.6M | NOS | $0.029 | $48K | MUNDRA SEA | SAVANNAH | SEA |
| 3 | Oct 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Tablet | 283.2K | NOS | $1.61 | $456K | MUNDRA SEA | SAVANNAH | SEA |
| 4 | Oct 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Tablet | 592.8K | NOS | $0.060 | $36K | MUNDRA SEA | SAVANNAH | SEA |
| 5 | Oct 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Tablet | 198.0K | NOS | $0.034 | $7K | MUNDRA SEA | SAVANNAH | SEA |
| 6 | Nov 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | 211.2K | NOS | $0.764 | $161K | MUNDRA SEA | Savannah | SEA | |
| 7 | Dec 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Tablet | 3.3M | NOS | $0.030 | $96K | MUNDRA SEA | Savannah | SEA |
| 8 | Dec 2025 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | Tablet | 3.3M | NOS | $0.030 | $98K | MUNDRA SEA | Savannah | SEA |
| SUPPLIER #2 — RPG LIFE SCIENCES LTD · 6 shipments · $792K | |||||||||||
| 9 | Dec 2025 | MEDI SUPPLIES LTD | Trinidad and Tobago | Tablet | 100 | NOS | $14.05 | $1K | MUMBAI AIR (SAHAR) | PORT OF SPAIN, PIARC | AIR |
| 10 | Dec 2025 | MEDI SUPPLIES LTD | Trinidad and Tobago | Tablet | 1.8K | NOS | $5.94 | $11K | MUMBAI AIR (SAHAR) | PORT OF SPAIN, PIARC | AIR |
| 11 | Dec 2025 | NEXT PHARMA SOURCING SAS | Colombia | Tablet | 9.7K | NOS | $2.98 | $29K | MUMBAI AIR (SAHAR) | BOGOTA | AIR |
| 12 | Dec 2025 | APOTEX INC | Canada | Tablet | 3.9M | TBS | $0.065 | $250K | NHAVA SHEVA SEA (JNPT) | Toronto | SEA |
| 13 | Dec 2025 | APOTEX INC | Canada | Tablet | 3.9M | TBS | $0.065 | $250K | NHAVA SHEVA SEA (JNPT) | Toronto | SEA |
| 14 | Dec 2025 | APOTEX INC | Canada | Tablet | 3.9M | TBS | $0.065 | $250K | NHAVA SHEVA SEA (JNPT) | Toronto | SEA |
| SUPPLIER #3 — AMNEAL PHARMACEUTICALS PVT LTD · 4 shipments · $86K | |||||||||||
| 15 | Oct 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 2.0K | NOS | $7.51 | $15K | MUNDRA SEA | Savannah | SEA |
| 16 | Dec 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 2.0K | NOS | $10.13 | $20K | AHMEDABAD AIR | CHICAGO O'HARE INT'L | AIR |
| 17 | Dec 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 682 | NOS | $8.13 | $6K | MUNDRA SEA | Savannah | SEA |
| 18 | Dec 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 4.4K | NOS | $10.13 | $45K | MUNDRA SEA | Savannah | SEA |
| SUPPLIER #4 — GLOBELA PHARMA PVT LTD · 1 shipments · $20K | |||||||||||
| 19 | Dec 2025 | UNLISTED BUYER | Peru | Tablet | 6.6K | NOS | $2.96 | $20K | MUMBAI AIR (SAHAR) | LIMA - | AIR |
| SUPPLIER #5 — EMCURE PHARMACEUTICALS LTD · 1 shipments · $0.0062 | |||||||||||
| 20 | Dec 2025 | EMCURE PHARMA CHILE S.P.A | Chile | Tablet | 1 | GMS | $0.0062 | $0.0062 | MUMBAI AIR (SAHAR) | SANTIAGO DE CHILE - | AIR |
| SUPPLIER #6 — CIPLA LTD · 1 shipments · $0.0000 | |||||||||||
| 21 | Dec 2025 | LASCO DISTRIBUTORS LTD | Jamaica | Tablet | 0 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Kingston | SEA |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
4 countries · 7 shipments · $101K · 4 Indian suppliers · 5 buyers
SHIPMENTS
7
USD
$101K
COUNTRIES
4
SUPPLIERS
4
BUYERS
5
HHI
9,946
concentrated
Top 4 destination countries in Oceania
1
Australia (99.7%)
$101K
2
Papua New Guinea (0.2%)
$247.52
3
Nauru (0.0%)
$15.32
4
Fiji (0.0%)
$8.99
Top 4 Indian suppliers into Oceania
1
RPG LIFE SCIENCES LTD
$101K
2
BIOLOG PHARMA PVT LTD
$247.52
3
HLL LIFECARE LTD
$15.32
4
MIOT MEDICAL SUPPLIES PVT LTD
$8.99
Top 4 Oceania importers
1
ARROW PHARMACEUTICALS PTY LTD · Australia
$68K
2
GENERIC PARTNERS PTY LTD · Australia
$33K
3
REPUBLIC OF NAURU - DEPARTMENT OF H · Nauru
$15.32
4
MIOT INVESTMENTS (FIJI) PTE LTD · Fiji
$8.99
Top 1 dosage forms
1
Tablet
$101K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 5 | $68K | $14K |
| Dec | 2 | $33K | $16K |
Shipment register · 7 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — RPG LIFE SCIENCES LTD · 4 shipments · $101K | |||||||||||
| 1 | Nov 2025 | ARROW PHARMACEUTICALS PTY LTD | Australia | Tablet | 1.9K | PCS | $3.50 | $7K | AHMEDABAD AIR | MELBOURNE | AIR |
| 2 | Nov 2025 | ARROW PHARMACEUTICALS PTY LTD | Australia | Tablet | 9.5K | PCS | $6.44 | $61K | AHMEDABAD AIR | MELBOURNE | AIR |
| 3 | Nov 2025 | ARROW PHARMACEUTICALS PTY LTD | Australia | Tablet | 72 | PCS | $6.77 | $487.60 | AHMEDABAD AIR | MELBOURNE | AIR |
| 4 | Dec 2025 | GENERIC PARTNERS PTY LTD | Australia | Tablet | 477.2K | TBS | $0.068 | $33K | NHAVA SHEVA SEA (JNPT) | Sydney | SEA |
| SUPPLIER #2 — BIOLOG PHARMA PVT LTD · 1 shipments · $247.52 | |||||||||||
| 5 | Nov 2025 | UNLISTED BUYER | Papua New Guinea | Tablet | 300 | NOS | $0.825 | $247.52 | AHMEDABAD AIR | PORT MORESBY | AIR |
| SUPPLIER #3 — HLL LIFECARE LTD · 1 shipments · $15.32 | |||||||||||
| 6 | Dec 2025 | REPUBLIC OF NAURU - DEPARTMENT OF H | Nauru | Tablet | 751 | NOS | $0.020 | $15.32 | DELHI AIR | NAURU ISLAND | AIR |
| SUPPLIER #4 — MIOT MEDICAL SUPPLIES PVT LTD · 1 shipments · $8.99 | |||||||||||
| 7 | Nov 2025 | MIOT INVESTMENTS (FIJI) PTE LTD | Fiji | Tablet | 45 | NOS | $0.200 | $8.99 | CHENNAI AIR | NADI | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 22 Indian azathioprine exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped azathioprine in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | RPG LIFE SCIENCES LTD | ANKLESHWAR | 33 | $1.40M | Tablet | Oceania, Europe |
| 2 | ZYDUS LIFESCIENCES LTD | AHMEDABAD | 8 | $950K | Tablet | Americas |
| 3 | GRANULES INDIA LTD | Visakhapatnam | 5 | $168K | Tablet | Europe |
| 4 | AMNEAL PHARMACEUTICALS PVT LTD | RAJODA | 4 | $86K | Tablet | Americas |
| 5 | CUBIT LIFESCIENCES LLP | SARKHEJ BAVLA HIGHWAY AT CHANGODAR | 1 | $21K | Tablet | Asia |
| 6 | GLOBELA PHARMA PVT LTD | SURAT | 1 | $20K | Tablet | Americas |
| 7 | WESTCOAST PHARMACEUTICAL WORKS LTD | AHMEDABAD | 1 | $8K | Tablet | Asia |
| 8 | BRUCK PHARMA PVT LTD | NANI | 3 | $6K | Tablet | Africa, Asia |
| 9 | VATS INDUSTRIES PVT LTD | NEW DELHI | 5 | $3K | Tablet, Injection | Asia |
| 10 | MDS ENTERPRISES | MUMBAI | 6 | $547.03 | Tablet | Africa, Asia |
| 11 | BARAKAH BIOHEALTH LLP | Tiruppur | 5 | $334.39 | Tablet | Africa |
| 12 | BIOLOG PHARMA PVT LTD | AHMEDABAD | 1 | $247.52 | Tablet | Oceania |
| 13 | BAKER & DAVIS PVT LTD | MUMBAI | 1 | $199.77 | Tablet | Asia |
| 14 | S P PHARMA ENTERPRISES | YELAPUR | 3 | $164.66 | Tablet | Africa |
| 15 | M T MADON EXPORTS | MUMBAI | 1 | $60.18 | Tablet | Africa |
| 16 | RUTVA MEDICARE | SURAT | 1 | $43.37 | Tablet | Africa |
| 17 | HLL LIFECARE LTD | UTTAR PRADESH | 1 | $15.32 | Tablet | Oceania |
| 18 | MIOT MEDICAL SUPPLIES PVT LTD | CHENNAI | 1 | $8.99 | Tablet | Oceania |
| 19 | GIANT INTERNATIONAL PVT LTD | JAIPUR | 1 | $8.14 | Injection | Africa |
| 20 | RMPL PHARMA LLP | MUMBAI | 2 | $0.288 | Tablet | Africa |
| 21 | EMCURE PHARMACEUTICALS LTD | PUNE | 1 | $0.0062 | Tablet | Americas |
| 22 | CIPLA LTD | PAREL MUMBAI MAHARASHTRA | 1 | $0.0000 | Tablet | Americas |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 27 global azathioprine importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian azathioprine in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCE SERVICES LLC | United States | 8 | $950K | ZYDUS LIFESCIENCES LTD | Tablet |
| 2 | APOTEX INC | Canada | 3 | $751K | RPG LIFE SCIENCES LTD | Tablet |
| 3 | AQVIDA GMBH | Germany | 17 | $258K | RPG LIFE SCIENCES LTD | Tablet |
| 4 | CSP VIATRIS SA | France | 1 | $128K | GRANULES INDIA LTD | Tablet |
| 5 | TILLOMED LABORATORIES LTD | United Kingdom | 1 | $102K | RPG LIFE SCIENCES LTD | Tablet |
| 6 | ELARA PHARMASERVICES LTD | United Kingdom | 2 | $88K | RPG LIFE SCIENCES LTD | Tablet |
| 7 | AMNEAL PHARMACEUTICALS LLC | United States | 4 | $86K | AMNEAL PHARMACEUTICA… | Tablet |
| 8 | ARROW PHARMACEUTICALS PTY LTD | Australia | 3 | $68K | RPG LIFE SCIENCES LTD | Tablet |
| 9 | PINYOPHARMACY LTD | Thailand | 2 | $62K | RPG LIFE SCIENCES LTD | Tablet |
| 10 | GENERIC PARTNERS PTY LTD | Australia | 1 | $33K | RPG LIFE SCIENCES LTD | Tablet |
| 11 | NEXT PHARMA SOURCING SAS | Colombia | 1 | $29K | RPG LIFE SCIENCES LTD | Tablet |
| 12 | MINISTRY OF HEALTH THE STATE COMPAN | Iraq | 1 | $21K | CUBIT LIFESCIENCES LLP | Tablet |
| 13 | VIATRIS HEALTHCARE GMBH | Germany | 2 | $18K | GRANULES INDIA LTD | Tablet |
| 14 | CSP P/O VIATRIS SA | France | 1 | $12K | GRANULES INDIA LTD | Tablet |
| 15 | MEDI SUPPLIES LTD | Trinidad and Tobago | 2 | $12K | RPG LIFE SCIENCES LTD | Tablet |
| 16 | MYLAN IRELAND LTD | Netherlands | 1 | $10K | GRANULES INDIA LTD | Tablet |
| 17 | ATLAS TRADING COMPANY | Iraq | 1 | $899.88 | VATS INDUSTRIES PVT … | Tablet |
| 18 | MERCKLE GMBH | Germany | 1 | $573.54 | RPG LIFE SCIENCES LTD | Tablet |
| 19 | ETEMAD MOSLEH LTD | Afghanistan | 1 | $199.77 | BAKER & DAVIS PVT LTD | Tablet |
| 20 | MED-CHIP PHARMACY | Zimbabwe | 3 | $164.66 | S P PHARMA ENTERPRISES | Tablet |
| 21 | SALAMA PHARMACUTICALS LTD | Kenya | 1 | $60.18 | M T MADON EXPORTS | Tablet |
| 22 | REPUBLIC OF NAURU - DEPARTMENT OF H | Nauru | 1 | $15.32 | HLL LIFECARE LTD | Tablet |
| 23 | MIOT INVESTMENTS (FIJI) PTE LTD | Fiji | 1 | $8.99 | MIOT MEDICAL SUPPLIE… | Tablet |
| 24 | T. CHOITHRAM & SONS | Sierra Leone | 1 | $8.14 | GIANT INTERNATIONAL … | Injection |
| 25 | EMCURE PHARMA CHILE S.P.A | Chile | 1 | $0.0062 | EMCURE PHARMACEUTICA… | Tablet |
| 26 | TRUST ANESTHETIC LTD | Afghanistan | 2 | $0.0000 | VATS INDUSTRIES PVT … | Injection |
| 27 | LASCO DISTRIBUTORS LTD | Jamaica | 1 | $0.0000 | CIPLA LTD | Tablet |
This report covers 86 2025-Q4 Azathioprine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/azathioprine
Talk to our trade analyst
Need a custom azathioprine report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/azathioprine
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Azathioprine product page
Live data, supplier directory, price trends, and trade route analysis